Proteomic analysis of circulating human monocytes in coronary artery disease

Molecular and Cellular Biochemistry

Volumn 360, Issue 1-2, 2012, Pages 181-188

  Poduri, Aruna ^a   Bahl, Ajay ^a   Talwar, Kewal K ^a   Khullar, Madhu ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Coronary artery disease; Inflammation; Monocytes; Proteomics; Two dimensional electrophoresis

Indexed keywords

ANTILIPEMIC AGENT; CALGRANULIN A; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN RECEPTOR PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY CARE UNIT; DIET RESTRICTION; FEMALE; HISTOPATHOLOGY; HOSPITAL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MONOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLUTATHIONE TRANSFERASE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LECTINS, C-TYPE; MALE; MANNOSE-BINDING LECTINS; MIDDLE AGED; MONOCYTES; PROTEOME; PROTEOMICS; RECEPTORS, CELL SURFACE; S100 PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIMENTIN;

EID: 83555164702     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1055-3     Document Type: Article

References (43)

1. DJ Rader A Daugherty 2008 Translating molecular discoveries into new therapies for atherosclerosis Nature 451 904 913 10.1038/nature06796 18288179 10.1038/nature06796 1:CAS:528:DC%2BD1cXit1ynsLc%3D (Pubitemid 351301745)
2. P Libby 2002 Inflammation in atherosclerosis Nature 20 868 874 10.1038/nature01323 10.1038/nature01323 (Pubitemid 36019640)
3. L Anderson 2005 Candidate-based proteomics in the search for biomarkers of cardiovascular disease J Physiol 563 23 60 10.1113/jphysiol.2004.080473 15611012 10.1113/jphysiol.2004.080473 1:CAS:528:DC%2BD2MXitVSntLk%3D (Pubitemid 40340365)
4. S Arab AO Gramolini P Ping T Kislinger B Stanley J van Eyk M Ouzounian DH MacLennan A Emili PP Liu 2006 Cardiovascular proteomics: tools to develop novel biomarkers and potential applications J Am Coll Cardiol 48 1733 1741 10.1016/j.jacc.2006.06.063 17084242 10.1016/j.jacc.2006.06.063 1:CAS:528:DC%2BD28XhtFOjtb7L (Pubitemid 44648616)
5. DK Arrell I Neverova JE Van Eyk 2001 Cardiovascular proteomics: evolution and potential Circ Res 8 763 773 10.1161/hh0801.090193 10.1161/hh0801.090193
6. M Jin JM Opalek CB Marsh HM Wu 2004 Proteome comparison of alveolar macrophages with monocytes reveals distinct protein characteristics Am J Respir Cell Mol Biol 31 322 329 10.1165/rcmb.2004-0080OC 15130903 10.1165/rcmb.2004- 0080OC 1:CAS:528:DC%2BD2cXnsVamsLg%3D (Pubitemid 39180302)
7. A Hryniewicz-Jankowska PK Choudhary SR Goodman 2007 Variation in monocyte proteome Exp Biol Med 7 967 976
8. M Jin PT Diaz T Bourgeois C Eng CB Marsh HM Wu 2006 Two-dimensional gel proteome reference map of blood monocytes Proteome Sci 4 16 10.1186/1477-5956-4- 16 16948843 10.1186/1477-5956-4-16 (Pubitemid 44420324)
9. MG Barderas J Tunon VM Darde F De la Cuesta MC Duran JJ Nacher N Tarín L López-Bescós J Egido F Vivanco 2007 Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile J Proteome Res 6 876 886 10.1021/pr0601990 17269745 10.1021/pr0601990 1:CAS:528:DC%2BD28Xhtlelt7jL (Pubitemid 46340192)
10. MG Barderas J Tuñón VM Dardé F De la Cuesta JJ Jiménez-Nácher N Tarín L López-Bescós J Egido F Vivanco 2009 Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome Proteomics 7 1982 1993 10.1002/pmic.200700583 10.1002/pmic.200700583
11. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 942051 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D
12. JD Hayes RC Strange 1995 Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress Free Radic Res 3 193 207 10.3109/10715769509147539
13. Y Yang MB Trent N He SD Lick P Zimniak YC Awasthi PJ Boor 2004 Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis Atherosclerosis 173 211 221 10.1016/j.atherosclerosis.2003.12.023 15064094 10.1016/j.atherosclerosis.2003. 12.023 1:CAS:528:DC%2BD2cXivVWkt70%3D (Pubitemid 38469788)
14. Z Cao Y Li 2002 Chemical induction of cellular antioxidants affords marked protection against oxidative injury in vascular smooth muscle cells Biochem Biophys Res Commun 292 50 57 10.1006/bbrc.2002.6614 11890670 10.1006/bbrc.2002.6614 1:CAS:528:DC%2BD38Xhslyhur4%3D (Pubitemid 34687327)
15. AS Doney S Lee GP Leese AD Morris CN Palmer 2005 Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study Circulation 22 2927 2934 10.1161/CIRCULATIONAHA.104.509224 10.1161/CIRCULATIONAHA.104.509224 (Pubitemid 40814185)
16. M Torzewski V Ochsenhirt AL Kleschyov M Oelze A Daiber H Li H Rossmann S Tsimikas K Reifenberg F Cheng HA Lehr S Blankenberg U Förstermann T Münzel KJ Lackner 2007 Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 4 850 857 10.1161/01.ATV.0000258809.47285.07 10.1161/01.ATV.0000258809.47285.07 (Pubitemid 46606716)
17. M Vicente-Manzanares F Sánchez-Madrid 2004 Role of the cytoskeleton during leukocyte responses Nat Rev Immunol 4 110 122 10.1038/nri1268 15040584 10.1038/nri1268 1:CAS:528:DC%2BD2cXhsVKqs7o%3D (Pubitemid 38209205)
18. R Geiben-Lynn M Kursar NV Brown MM Addo H Shau J Lieberman AD Luster BD Walker 2003 HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family J Biol Chem 278 1569 1574 10.1074/jbc.M209964200 12421812 10.1074/jbc.M209964200 1:CAS:528:DC%2BD3sXisFyhtA%3D%3D (Pubitemid 36801385)
19. MR Logan SO Odemuyiwa R Moqbel 2003 Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion J Allergy Clin Immunol 5 923 932 10.1067/mai.2003.1573 (Pubitemid 36570847)
20. I Jordens M Marsman C Kuijl J Neefjes 2005 Rab proteins, connecting transport and vesicle fusion Traffic 6 1070 1077 10.1111/j.1600-0854.2005.00336 16262719 10.1111/j.1600-0854.2005.00336.x 1:CAS:528:DC%2BD2MXht1Ogtr3I (Pubitemid 41632260)
21. H Qin T Ishiwata R Wang M Kudo M Yokoyama Z Naito G Asano 2000 Effects of extracellular matrix on phenotype modulation and MAPK transduction of rat aortic smooth muscle cells in vitro Exp Mol Pathol 69 79 90 10.1006/exmp.2000. 2321 11001858 10.1006/exmp.2000.2321 1:CAS:528:DC%2BD3cXms1yitrg%3D
22. S Jurcevic ME Ainsworth A Pomerance JD Smith DR Robinson MJ Dunn MH Yacoub ML Rose 2001 Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation Transplantation 7 886 892 10.1097/00007890-200104150-00011 (Pubitemid 32417348)
23. JH Kang H Kim MS Choi WH Lee TL Huh YB Park BJ Moon OS Kwon 2006 Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins Proteomics 6 1261 1273 10.1002/pmic.200500290 16402358 10.1002/pmic.200500290 1:CAS:528:DC%2BD28XitlGns7w%3D
24. AK Heidenthal PC Weber F Lottspeich N Hrboticky 2000 The binding in vitro of modified LDL to the intermediate filament protein vimentin Biochem Biophys Res Commun 267 49 53 10.1006/bbrc.1999.1940 10623572 10.1006/bbrc.1999.1940 1:CAS:528:DC%2BD3cXht1Glug%3D%3D (Pubitemid 30072505)
25. TT Keller SI van Leuven MC Meuwese NJ Wareham R Luben ES Stroes CE Hack M Levi KT Khaw SM Boekholdt 2006 Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women Arterioscler Thromb Vasc Biol 10 2345 2350 10.1161/01.ATV.0000240517.69201.77 10.1161/01.ATV.0000240517.69201.77 (Pubitemid 44465732)
26. M Gadjeva K Takahashi S Thiel 2004 Mannan-binding lectin-a soluble pattern recognition molecule Mol Immunol 41 113 121 10.1016/j.molimm.2004.03.015 15159056 10.1016/j.molimm.2004.03.015 1:CAS:528:DC%2BD2cXktFKlu74%3D (Pubitemid 38678615)
27. MW Turner 1996 Mannose-binding lectin: the pluripotent molecule of the innate immune system Immunol Today 17 532 540 8961631 10.1016/0167-5699(96) 10062-1 1:CAS:528:DyaK28XntVKrsrY%3D (Pubitemid 26373253)
28. SV Petersen S Thiel JC Jensenius 2001 The mannan-binding lectin pathway of complement activation: biology and disease association Mol Immunol 38 133 149 10.1016/S0161-5890(01)00038-4 11532276 10.1016/S0161-5890(01)00038-4 1:STN:280:DC%2BD3MvptVyqtA%3D%3D (Pubitemid 32786772)
29. A Roos LH Bouwman DJ van Gijlswijk-Janssen MC Faber-Krol GL Stahl MR Daha 2001 Human IgA activates the complement system via the mannan-binding lectin pathway J Immunol 5 2861 2868 (Pubitemid 32768920)
30. CA Ogden A de Cathelineau PR Hoffmann D Bratton B Ghebrehiwet VA Fadok PM Henson 2001 C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells J Exp Med 194 781 795 10.1084/jem.194.6.781 11560994 10.1084/jem.194.6.781 1:CAS:528:DC%2BD3MXmvFGgsrc%3D (Pubitemid 32983014)
31. I Ghiran SF Barbashov LB Klickstein SW Tas JC Jensenius A Nicholson-Weller 2000 Complement receptor 1/CD35 is a receptor for mannan-binding lectin J Exp Med 192 1797 1808 10.1084/jem.192.12.1797 11120776 10.1084/jem.192.12.1797 1:CAS:528:DC%2BD3cXptVKmtr4%3D (Pubitemid 32049772)
32. WS Speidl M Exner J Amighi SP Kastl G Zorn G Maurer O Wagner K Huber E Minar J Wojta M Schillinger 2005 Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis Eur Heart J 26 2294 2299 10.1093/eurheartj/ehi339 15917276 10.1093/eurheartj/ehi339 1:CAS:528:DC%2BD2MXht1Kku7rM (Pubitemid 41541394)
33. R Oksjoki H Jarva PT Kovanen P Laine S Meri MO Pentikainen 2003 Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation Arterioscler Thromb Vasc Biol 23 630 636 10.1161/01.ATV.0000057808.91263.A4 12615690 10.1161/01.ATV.0000057808.91263.A4 1:CAS:528:DC%2BD3sXisFKgtL4%3D (Pubitemid 36438076)
34. J Zhu AA Quyumi H Wu G Csako D Rott A Zalles-Ganley J Ogunmakinwa J Halcox SE Epstein 2003 Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease Arterioscler Thromb Vasc Biol 23 1055 1059 10.1161/01.ATV.0000074899.60898.FD 12730089 10.1161/01.ATV.0000074899.60898.FD 1:CAS:528:DC%2BD3sXktlant7o%3D (Pubitemid 36713560)
35. A Kol T Bourcier AH Lichtman P Libby 1999 Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages J Clin Invest 103 571 577 10.1172/JCI5310 10021466 10.1172/JCI5310 1:CAS:528:DyaK1MXhslWqsb4%3D (Pubitemid 29094058)
36. A Shamaei-Tousi JW Stephens R Bin JA Cooper A Steptoe ARM Coates B Henderson SE Humphries 2006 Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus Eur Heart J 27 1565 1570 10.1093/eurheartj/ehl081 16762985 10.1093/eurheartj/ehl081 1:CAS:528:DC%2BD28XotV2hs78%3D (Pubitemid 43954915)
37. RK Kanwar JR Kanwar D Wang DJ Ormrod GW Krissansen 2001 Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice Arterioscler Thromb Vasc Biol 12 1991 1997 10.1161/hq1201.100263 10.1161/hq1201.100263 (Pubitemid 34219752)
38. Z Han QA Truong S Park JL Breslow 2003 Two Hsp70 family members expressed in atherosclerotic lesions Proc Natl Acad Sci USA 3 1256 1261 10.1073/pnas.252764399 10.1073/pnas.252764399 (Pubitemid 36183989)
39. PA Svensson A Asea MC Englund MA Bausero M Jernås O Wiklund BG Ohlsson LM Carlsson B Carlsson 2006 Major role of HSP70 as a paracrine inducer of cytokine production in human oxidized LDL treated macrophages Atherosclerosis 185 32 38 10.1016/j.atherosclerosis.2005.05.007 15993884 10.1016/j. atherosclerosis.2005.05.007 1:CAS:528:DC%2BD28Xos1ejsQ%3D%3D (Pubitemid 43117548)
40. S Westaby P Johnson AJ Parry S Blomquist JO Solen C Alling R Pillai DP Taggart C Grebenik 1996 Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass Ann Thorac Surg 61 88 92 10.1016/0003-4975(95)00904-3 8561645 10.1016/0003-4975(95)00904-3 1:STN:280:DyaK287ks1aquw%3D%3D (Pubitemid 26053495)
41. R Ramasamy SF Yan AM Schmidt 2005 The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond Trends Cardiovasc Med 15 237 243 10.1016/j.tcm.2005.08.003 16226677 10.1016/j.tcm.2005.08.003 1:CAS:528:DC%2BD2MXhtFWhtL7K (Pubitemid 41437905)
42. A Rammes J Roth M Goebeler M Kelmpt C Sorg 1997 Myeloid related protein (MRP8) and MRP-14, calcium binding proteins of the S100 family are secreted by activated monocytes via novel tubulin-dependent pathway J Biol Chem 272 9496 9502 10.1074/jbc.272.14.9496 9083090 10.1074/jbc.272.14.9496 1:CAS:528:DyaK2sXisVGqsbY%3D (Pubitemid 27154966)
43. MM McCormick F Rahimi YV Bobryshev K Gaus H Zreiqat H Cai RSA Lord CL Geczy 2005 S100A8 and S100A9 in human arterial wall. Implications for atherogenesis J Biol Chem 280 41521 41529 10.1074/jbc.M509442200 16216873 10.1074/jbc.M509442200 1:CAS:528:DC%2BD2MXhtlShsbvL (Pubitemid 41832213)